Akshay Maniyeri Suresh

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Mild Cognitive Impairment

Respiratory Syndrome Coronavirus

Palliative Care

Molecular Docking

Top Venues

Archives of microbiology

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Aravind Ayyolath, Anoop Kallingal, Varun Thachan Kundil, Akshay Maniyeri Suresh, Jayadevi Variyar E
Investigating the disease-modifying properties of sclerotiorin in Alzheimer's therapy using acetylcholinesterase inhibition. Chemical biology & drug design (2023)
Tomy Muringayil Joseph, Akshay Maniyeri Suresh, Debarshi Kar Mahapatra, Józef Tadeusz Haponiuk, Sabu Thomas
The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein. Nutrients 14 (23) (2022)
Anoop Kallingal, Aravind Ayyolath, Varun Thachan Kundil, Akshay Maniyeri Suresh, Tomy Muringayil Joseph, Józef Tadeusz Haponiuk, Sabu Thomas, Anu Augustine
Divulging the anti-acetylcholinesterase activity of Colletotrichum lentis strain KU1 extract as sustainable AChE active site inhibitors. Archives of microbiology 204 (12) (2022)
Tomy Muringayil Joseph, Akshay Maniyeri Suresh, Debarshi Kar Mahapatra, Józef Tadeusz Haponiuk, Sabu Thomas
The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein. Nutrients 14 (23) (2022)
Tomy Muringayil Joseph, Akshay Maniyeri Suresh, Debarshi Kar Mahapatra, Józef Tadeusz Haponiuk, Sabu Thomas
The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein. Nutrients 14 (23) (2022)
Tomy Muringayil Joseph, Akshay Maniyeri Suresh, Debarshi Kar Mahapatra, Józef Tadeusz Haponiuk, Sabu Thomas
The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein. Nutrients 14 (23) (2022)